The Ministry of Health announces the public to one type of health product which has been tested and found to be adulterated with undeclared, potent western medicine which can cause adverse effects that are potentially hazardous to the people using them.

The Pharmacy Section, Department of Scientific Services has found that the Titan Capsules product, released by Laboratory Emansi Russia has been affected with Taladafil. The Ministry of Health has not issued any approval for the importation for the sale of this product. Following this finding, the product is not allowed to be imported and sold in Brunei Darussalam. Members of the public who have purchased or used this product are advised to stop using it immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using the product.

Members of the public involved in the retail of this product (including online retail such as through Facebook, are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months imprisonment. For more information, members of the public can contact the Compliance and Licensing Section at 2393298 extension 208; or e-mail to pharmacy.enforcement@moh.gov.bn or go directly to 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services Building, Kampung Madaras, Mukim Gadong A; or call the Talian Darussalam 123.

Source: Radio Television Brunei